Circulating Angiogenic Factors in Preeclampsia

This publication has 72 references indexed in Scilit:

• Maternal Serum sFlt1 Concentration Is an Early and Reliable Predictive Marker of Preeclampsia
  Clinical Chemistry, 2004
• Insulin Resistance and Alterations in Angiogenesis
  Hypertension, 2004
• Circulating Angiogenic Factors and the Risk of Preeclampsia
  New England Journal of Medicine, 2004
• Second‐ and third‐trimester serum levels of placental proteins in preeclampsia and small‐for‐gestational age pregnancies
  Acta Obstetricia et Gynecologica Scandinavica, 2003
• Expression and Function of Placenta Growth Factor: Implications for Abnormal Placentation
  Journal of the Society for Gynecologic Investigation, 2003
• Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia.
  Journal of Clinical Investigation, 1996
• Atrial natriuretic peptide (ANP) in preeclampsia-like syndrome in a rat model
  Experimental and Clinical Endocrinology & Diabetes, 1995
• Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.
  Proceedings of the National Academy of Sciences, 1993
• Sera From Preeclamptic Women Specifically Activate Human Umbilical Vein Endothelial Cells In Vitro: Morphological and Biochemical Evidence
  American Journal of Reproductive Immunology, 1992
• A Study of Angiotensin II Pressor Response throughout Primigravid Pregnancy
  Journal of Clinical Investigation, 1973